300 related articles for article (PubMed ID: 28060811)
1. Stromal Fibroblasts from the Interface Zone of Triple Negative Breast Carcinomas Induced Epithelial-Mesenchymal Transition and its Inhibition by Emodin.
Hsu HC; Liu LC; Wang HY; Hung CM; Lin YC; Ho CT; Way TD
PLoS One; 2017; 12(1):e0164661. PubMed ID: 28060811
[TBL] [Abstract][Full Text] [Related]
2. Stromal fibroblasts from the interface zone of human breast carcinomas induce an epithelial-mesenchymal transition-like state in breast cancer cells in vitro.
Gao MQ; Kim BG; Kang S; Choi YP; Park H; Kang KS; Cho NH
J Cell Sci; 2010 Oct; 123(Pt 20):3507-14. PubMed ID: 20841377
[TBL] [Abstract][Full Text] [Related]
3. Cancer-Associated Fibroblasts Autophagy Enhances Progression of Triple-Negative Breast Cancer Cells.
Wang M; Zhang J; Huang Y; Ji S; Shao G; Feng S; Chen D; Zhao K; Wang Z; Wu A
Med Sci Monit; 2017 Aug; 23():3904-3912. PubMed ID: 28802099
[TBL] [Abstract][Full Text] [Related]
4. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer.
Takai K; Le A; Weaver VM; Werb Z
Oncotarget; 2016 Dec; 7(50):82889-82901. PubMed ID: 27756881
[TBL] [Abstract][Full Text] [Related]
5. Roles of fibroblasts from the interface zone in invasion, migration, proliferation and apoptosis of gastric adenocarcinoma.
Shan LH; Sun WG; Han W; Qi L; Yang C; Chai CC; Yao K; Zhou QF; Wu HM; Wang LF; Liu JR
J Clin Pathol; 2012 Oct; 65(10):888-95. PubMed ID: 22844068
[TBL] [Abstract][Full Text] [Related]
6. Emodin inhibits epithelial‑mesenchymal transition and metastasis of triple negative breast cancer via antagonism of CC‑chemokine ligand 5 secreted from adipocytes.
Song X; Zhou X; Qin Y; Yang J; Wang Y; Sun Z; Yu K; Zhang S; Liu S
Int J Mol Med; 2018 Jul; 42(1):579-588. PubMed ID: 29693154
[TBL] [Abstract][Full Text] [Related]
7. Cancer-associated fibroblasts induce epithelial-mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling.
Goulet CR; Champagne A; Bernard G; Vandal D; Chabaud S; Pouliot F; Bolduc S
BMC Cancer; 2019 Feb; 19(1):137. PubMed ID: 30744595
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of FGF9 and NOVA1 in cancer-associated fibroblasts promotes cell proliferation, invasion and migration of triple negative breast cancer.
Zhang B; Liu Y; Yu J; Lin X
Drug Dev Res; 2024 May; 85(3):e22185. PubMed ID: 38657094
[TBL] [Abstract][Full Text] [Related]
9. Snail1-dependent cancer-associated fibroblasts induce epithelial-mesenchymal transition in lung cancer cells via exosomes.
You J; Li M; Cao LM; Gu QH; Deng PB; Tan Y; Hu CP
QJM; 2019 Aug; 112(8):581-590. PubMed ID: 31106370
[TBL] [Abstract][Full Text] [Related]
10. Cancer-associated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-β signalling.
Yu Y; Xiao CH; Tan LD; Wang QS; Li XQ; Feng YM
Br J Cancer; 2014 Feb; 110(3):724-32. PubMed ID: 24335925
[TBL] [Abstract][Full Text] [Related]
11. Cancer-associated fibroblasts in a human HEp-2 established laryngeal xenografted tumor are not derived from cancer cells through epithelial-mesenchymal transition, phenotypically activated but karyotypically normal.
Wang M; Wu CP; Pan JY; Zheng WW; Cao XJ; Fan GK
PLoS One; 2015; 10(2):e0117405. PubMed ID: 25658113
[TBL] [Abstract][Full Text] [Related]
12. Emodin reduces Breast Cancer Lung Metastasis by suppressing Macrophage-induced Breast Cancer Cell Epithelial-mesenchymal transition and Cancer Stem Cell formation.
Liu Q; Hodge J; Wang J; Wang Y; Wang L; Singh U; Li Y; Yao Y; Wang D; Ai W; Nagarkatti P; Chen H; Xu P; Murphy EA; Fan D
Theranostics; 2020; 10(18):8365-8381. PubMed ID: 32724475
[TBL] [Abstract][Full Text] [Related]
13. IL-6 Secreted from Cancer-Associated Fibroblasts Mediates Chemoresistance in NSCLC by Increasing Epithelial-Mesenchymal Transition Signaling.
Shintani Y; Fujiwara A; Kimura T; Kawamura T; Funaki S; Minami M; Okumura M
J Thorac Oncol; 2016 Sep; 11(9):1482-92. PubMed ID: 27287412
[TBL] [Abstract][Full Text] [Related]
14. Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts.
Baroni S; Romero-Cordoba S; Plantamura I; Dugo M; D'Ippolito E; Cataldo A; Cosentino G; Angeloni V; Rossini A; Daidone MG; Iorio MV
Cell Death Dis; 2016 Jul; 7(7):e2312. PubMed ID: 27468688
[TBL] [Abstract][Full Text] [Related]
15. Type 2 Diabetes Mellitus Promotes the Differentiation of Adipose Tissue-Derived Mesenchymal Stem Cells into Cancer-Associated Fibroblasts, Induced by Breast Cancer Cells.
Chang YH; Ngo NH; Vuong CK; Yamashita T; Osaka M; Hiramatsu Y; Ohneda O
Stem Cells Dev; 2022 Nov; 31(21-22):659-671. PubMed ID: 35734905
[TBL] [Abstract][Full Text] [Related]
16. Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial-mesenchymal transition and fibroblast activation.
Guan R; Wang X; Zhao X; Song N; Zhu J; Wang J; Wang J; Xia C; Chen Y; Zhu D; Shen L
Sci Rep; 2016 Oct; 6():35696. PubMed ID: 27774992
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells.
Soon PS; Kim E; Pon CK; Gill AJ; Moore K; Spillane AJ; Benn DE; Baxter RC
Endocr Relat Cancer; 2013 Feb; 20(1):1-12. PubMed ID: 23111755
[TBL] [Abstract][Full Text] [Related]
18. IM-412 inhibits the invasion of human breast carcinoma cells by blocking FGFR-mediated signaling.
Jung SY; Yi JY; Kim MH; Song KH; Kang SM; Ahn J; Hwang SG; Nam KY; Song JY
Oncol Rep; 2015 Nov; 34(5):2731-7. PubMed ID: 26351897
[TBL] [Abstract][Full Text] [Related]
19. ITGB4-mediated metabolic reprogramming of cancer-associated fibroblasts.
Sung JS; Kang CW; Kang S; Jang Y; Chae YC; Kim BG; Cho NH
Oncogene; 2020 Jan; 39(3):664-676. PubMed ID: 31534187
[TBL] [Abstract][Full Text] [Related]
20. Activation of fibroblasts by nicotine promotes the epithelial-mesenchymal transition and motility of breast cancer cells.
Chen PC; Lee WY; Ling HH; Cheng CH; Chen KC; Lin CW
J Cell Physiol; 2018 Jun; 233(6):4972-4980. PubMed ID: 29215705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]